DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Thalomid (Thalidomide) - Disease Progression - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Disease Progression ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) where reactions include disease progression. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Thalomid side effects in female

Reported by a physician from United States on 2012-07-25

Patient: female, weighing 65.4 kg (143.8 pounds)

Reactions: Drug Ineffective, Disease Progression

Drug(s) suspected as cause:
Thalomid

Other drugs received by patient: Lasix; Decadron



Possible Thalomid side effects in

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-16

Patient:

Reactions: Graft Versus Host Disease, Pulmonary Embolism, Toxicity To Various Agents, Polyneuropathy, Disease Progression, Death, Embolism Venous, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: induction therapy, 200 mg escalated to 400 mg, qd, with vte prophylaxis
    Administration route: Oral
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 200 milligram/sq. meter

Cyclophosphamide
    Dosage: 1000 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral

Adriamycin PFS
    Dosage: 15 milligram/sq. meter

Thalomid
    Dosage: maintenance therapy, 50 mg qd, without vte prophylaxis
    Administration route: Oral

Adriamycin PFS
    Dosage: 9 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen; Mycophenolate Mophetil; Cyclosporine; Nadroparine



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-07-11

Patient: female, weighing 65.4 kg (143.8 pounds)

Reactions: Drug Ineffective, Adverse Event, Disease Progression

Drug(s) suspected as cause:
Thalomid

Other drugs received by patient: Lasix; Decadron



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-07-05

Patient: female, weighing 65.4 kg (143.8 pounds)

Reactions: Drug Ineffective, Adverse Event, Disease Progression

Drug(s) suspected as cause:
Thalomid

Other drugs received by patient: Decadron; Lasix



Possible Thalomid side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-05-08

Patient:

Reactions: Neuropathy Peripheral, Pneumonia, Diabetes Mellitus, Sepsis, Anaemia, Neutropenia, Thrombocytopenia, Disease Progression, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Bortezomib
    Indication: Multiple Myeloma

Bortezomib

Vincristine
    Indication: Multiple Myeloma

Adriamycin PFS
    Indication: Multiple Myeloma

Other drugs received by patient: Aspirin; Neupogen; Melphalan Hydrochloride



Possible Thalomid side effects in

Reported by a physician from United States on 2012-04-02

Patient:

Reactions: Gastrointestinal Toxicity, Disease Progression, Haematotoxicity, Death, Hepatobiliary Disease, Metabolic Disorder, Electrolyte Imbalance, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 12 milligram

Melphalan Hydrochloride
    Dosage: 5 milligram/sq. meter

Cyclophosphamide
    Dosage: 75 microgram/sq. meter

Thalomid
    Dosage: 100 milligram
    Administration route: Oral

Melphalan Hydrochloride
    Dosage: 10 milligram/sq. meter
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 20 milligram/sq. meter

Doxorubicin HCL
    Dosage: 10 microgram/sq. meter

Cyclophosphamide
    Dosage: 75 microgram/sq. meter

Bortezomib
    Dosage: 1 milligram/sq. meter
    Indication: Multiple Myeloma

Bortezomib
    Dosage: 1 milligram/sq. meter

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Dexamethasone
    Dosage: 20 milligram

Dexamethasone
    Dosage: 40 milligram

Melphalan Hydrochloride
    Dosage: 4 milligram/sq. meter

Cisplatin
    Dosage: 75 microgram/sq. meter

Doxorubicin HCL
    Dosage: 10 microgram/sq. meter
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 75 microgram/sq. meter

Revlimid
    Dosage: 25 milligram
    Administration route: Oral

Thalomid
    Dosage: 100 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 20 milligram

Melphalan Hydrochloride
    Dosage: 5 milligram/sq. meter

Cisplatin
    Dosage: 10 microgram/sq. meter
    Indication: Multiple Myeloma

Cyclophosphamide
    Dosage: 100 microgram/sq. meter

Etoposide
    Dosage: 60 microgram/sq. meter

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Bortezomib
    Dosage: 1 milligram/sq. meter

Dexamethasone
    Dosage: 20 milligram

Cisplatin
    Dosage: 75 microgram/sq. meter

Cyclophosphamide
    Dosage: 100 microgram/sq. meter

Etoposide
    Dosage: 80 microgram/sq. meter

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 20 milligram

Cisplatin
    Dosage: 10 microgram/sq. meter

Cisplatin
    Dosage: 10 microgram/sq. meter

Doxorubicin HCL
    Dosage: 75 microgram/sq. meter

Cyclophosphamide
    Dosage: 400 microgram/sq. meter
    Indication: Multiple Myeloma

Etoposide
    Dosage: 40 microgram/sq. meter
    Indication: Multiple Myeloma

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 20 milligram

Melphalan Hydrochloride
    Dosage: 20 milligram/sq. meter

Etoposide
    Dosage: 80 microgram/sq. meter

Thalomid
    Dosage: 50 milligram
    Administration route: Oral

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Dexamethasone
    Dosage: 20 milligram

Dexamethasone
    Dosage: 20 milligram

Doxorubicin HCL
    Dosage: 10 microgram/sq. meter

Etoposide
    Dosage: 60 microgram/sq. meter



Possible Thalomid side effects in 54 year old male

Reported by a physician from United States on 2012-03-23

Patient: 54 year old male

Reactions: Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Thalomid
    Indication: Product Used FOR Unknown Indication

Revlimid
    Dosage: 15 mg, 1 in 1 d, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-01

Other drugs received by patient: Cisplatin; Etoposide; Dexamethasone; Cyclophosphamide; Adriamycin PFS



Possible Thalomid side effects in

Reported by a individual with unspecified qualification from United States on 2012-03-13

Patient:

Reactions: Pneumonia Aspiration, Hyperglycaemia, Anaemia, Muscular Weakness, Rash, Constipation, Hypercalcaemia, Disease Progression, Fatigue, Neuropathy Peripheral, Oedema Peripheral, Neutropenia, Thrombocytopenia, Asthenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-11-01
    End date: 2011-01-01

Revlimid
    Dosage: 50 milligram
    Administration route: Oral
    End date: 2011-01-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-11-01

Other drugs received by patient: Dexamethasone; Aspirin; Bisphosphonates; Neupogen; Blood Product Support; Warfarin Sodium; Heparin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014